Expertise in
23
conditions

Dr. John Belperio

Intensive Care Medicine
Office
200 Medical Plz Ste 365B-2, 
Los Angeles, CA 
Offers Telehealth
Expertise in
23
conditions
Office
200 Medical Plz Ste 365B-2, 
Los Angeles, CA 

Overview

John Belperio is an Intensive Care Medicine provider in Los Angeles, California. Dr. Belperio is highly rated in 23 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Bronchiolitis Obliterans, Lung Transplant, and Endoscopy.

His clinical research consists of co-authoring 146 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in CA

Hospital Affiliations

Ronald Reagan UCLA Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Office
200 Medical Plz Ste 365B-2, Los Angeles, CA 90095

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Clinical Trials in Organ Transplantation Extension Study (CTOT-ES)
Enrollment Status: Completed
Publish Date: March 21, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Potential Therapy With MACITENTAN in the Treatment of Chronic Lung Allograft Dysfunction (CLAD) After Lung Transplantation
Enrollment Status: Withdrawn
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
A Prospective Single Center Randomized Trial of Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation.
Enrollment Status: Withdrawn
Publish Date: September 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
A Prospective Multicenter Observational Cohort Study to Define the Risks Factors, Mechanisms, and Manifestations of Chronic Lung Allograft Dysfunction (CLAD) Phenotypes (CTOT-20)
Enrollment Status: Completed
Publish Date: December 17, 2019
Intervention Type: Procedure
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Treatment of Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Hypertension With Bosentan: A Single Center Pilot Study
Enrollment Status: Withdrawn
Publish Date: March 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

146 Total Publications

Emerging roles for complement in lung transplantation.
Emerging roles for complement in lung transplantation.
Journal: The Journal of clinical investigation
Published: October 01, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Igor Barjaktarevic
Intensive Care Medicine
Expertise in
14
conditions
Dr. Igor Barjaktarevic
Intensive Care Medicine

Office

200 UCLA Medical Plz Ste 365B1, 
Los Angeles, CA 
 (0.5 miles away)
310-825-8061
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Igor Barjaktarevic is an Intensive Care Medicine provider in Los Angeles, California. Dr. Barjaktarevic is highly rated in 14 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), Thrombectomy, and Endoscopy.

Expertise in
11
conditions
Dr. Stephen Weigt
Intensive Care Medicine
Expertise in
11
conditions
Dr. Stephen Weigt
Intensive Care Medicine

Office

200 Medical Plz Ste 365, 
Los Angeles, CA 
 (0.5 miles away)
310-825-8061
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Weigt is an Intensive Care Medicine provider in Los Angeles, California. Dr. Weigt is highly rated in 11 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Transplant.

Expertise in
10
conditions
Dr. Tisha Wang
Intensive Care Medicine
Expertise in
10
conditions
Dr. Tisha Wang
Intensive Care Medicine

Office

200 Medical Plz Ste 365530, 
Los Angeles, CA 
 (0.5 miles away)
310-825-8061
Languages Spoken:
English
See accepted insurances

Tisha Wang is an Intensive Care Medicine provider in Los Angeles, California. Dr. Wang is highly rated in 10 conditions, according to our data. Her top areas of expertise are Pulmonary Alveolar Proteinosis, End-Stage Renal Disease (ESRD), Pneumonia, Gastrostomy, and Lung Transplant.

Frequently Asked Questions about Dr. John Belperio

How do I make an appointment with Dr. John Belperio?

You can book an appointment with Dr. John Belperio by calling their office at 310-825-8061. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John Belperio a top-rated expert for Lung Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John Belperio is classified as an Elite expert for Lung Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John Belperio specialize in?

While Dr. John Belperio is a Intensive Care Medicine, they have specific expertise in Lung Transplant, Acute Interstitial Pneumonia, and Interstitial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. John Belperio participate in research or clinical trials?

Yes. Dr. John Belperio has published 146 articles and abstracts on conditions like Lung Transplant. You can view a list of Dr. John Belperio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John Belperio accept my insurance?

Dr. John Belperio accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-825-8061 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Belperio's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile